Single-Dose Mucosal Replicon-Particle Vaccine Protects against Lethal Nipah Virus Infection Up to 3 Days after Vaccination

The authors reported on the clinical impact of a novel Nipah virus-derived nonspreading replicon particle lacking the fusion protein gene as a vaccine in three small animal models of disease.